Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro

1 Dec 2016

Abstract excerpt

BACKGROUND: Estrogen receptor β (ERβ) is expressed in the majority of invasive breast cancer cases, irrespective of their subtype, including triple-negative breast cancer (TNBC). Thus, ERβ might be a potential target for therapy of this challenging cancer type. In this in vitro study, we examined the role of ERβ in invasion of two triple-negative breast cancer cell lines. METHODS: MDA-MB-231 and HS578T breast...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Cancer, Stress, Anesthesia, and Immune Response
Share to Estrogen and related hormone effects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28003019
DOI: 10.1186/s12885-016-2973-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitroPMID 28003019Read ↗

Insights into the Role of Estrogen Receptor β in Triple-Negative Breast CancerSemantic proximity Read ↗

Research Resource: Global Identification of Estrogen Receptor β Target Genes in Triple Negative Breast Cancer CellsSemantic proximity Read ↗

Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast CancerSemantic proximity Read ↗

ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function.Semantic proximity Read ↗

Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor SuppressorSemantic proximity Read ↗

Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cellsSemantic proximity Read ↗

Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide <i>In Vivo</i>Semantic proximity Read ↗

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast CancerSemantic proximity Read ↗

Estrogen Signals through ERβ in Breast Cancer; What We Have Learned since the Discovery of the ReceptorSemantic proximity Read ↗

ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 functionSemantic proximity Read ↗

Thyroid hormone enhances estrogen-mediated proliferation and cell cycle regulatory pathways in steroid receptor-positive breast CancerSemantic proximity Read ↗

Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.